Gene · 6839
Papers3,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation. | J Gen Virol | 2021 | 33427604 | PubTator, text mining | PubMed |
| Chromatin Manipulation and Editing: Challenges, New Technologies and Their Use in Plants. | Int J Mol Sci | 2021 | 33419220 | PubTator, text mining | PubMed |
Acute high folic acid treatment in SH-SY5Y cells with and without MTHFR function leads to gene expression changes in epigenetic modifying enzymes, changes in epigenetic marks, and changes in dendritic spine densities. | PLoS One | 2021 | 33411826 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. | Biomed Pharmacother | 2021 | 33378975 | PubTator, text mining | PubMed |
| Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression. | Biochim Biophys Acta Rev Cancer | 2021 | 33373647 | PubTator, text mining | PubMed |
| FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells. | Cell | 2021 | 33357448 | PubTator, text mining | PubMed |
| Close to the edge: Heterochromatin at the nucleolar and nuclear peripheries. | Biochim Biophys Acta Gene Regul Mech | 2021 | 33307247 | PubTator, text mining | PubMed |
| Genome-wide investigation of the dynamic changes of epigenome modifications after global DNA methylation editing. | Nucleic Acids Res | 2021 | 33300025 | PubTator, text mining | PubMed |
| The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective. | Cell Mol Life Sci | 2021 | 33263776 | PubTator, text mining | PubMed |
| STAT3 enhances radiation-induced tumor migration, invasion and stem-like properties of bladder cancer. | Mol Med Rep | 2021 | 33236137 | PubTator, text mining | PubMed |
| MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression. | Hum Cell | 2021 | 33196969 | PubTator, text mining | PubMed |
| SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90. | Biomol Ther (Seoul) | 2021 | 33162400 | PubTator, text mining | PubMed |
| Targeting post-translational histone modifying enzymes in glioblastoma. | Pharmacol Ther | 2021 | 33144118 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe? | Gut Liver | 2021 | 33087588 | PubTator, text mining | PubMed |
| Identification of human adenovirus replication inhibitors from a library of small molecules targeting cellular epigenetic regulators. | Virology | 2021 | 33032802 | PubTator, text mining | PubMed |
| Cellular senescence in cancer: from mechanisms to detection. | Mol Oncol | 2021 | 32981205 | PubTator, text mining | PubMed |
| Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development. | Bone | 2021 | 32979540 | PubTator, text mining | PubMed |
| Computational methods and next-generation sequencing approaches to analyze epigenetics data: Profiling of methods and applications. | Methods | 2021 | 32941995 | PubTator, text mining | PubMed |
| Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. | J Cell Physiol | 2021 | 32840881 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6839/papers?page=51